Recommendations for achieving interoperable and shareable medical data in the USA
- PMID: 35865358
- PMCID: PMC9293957
- DOI: 10.1038/s43856-022-00148-x
Recommendations for achieving interoperable and shareable medical data in the USA
Abstract
Easy access to large quantities of accurate health data is required to understand medical and scientific information in real-time; evaluate public health measures before, during, and after times of crisis; and prevent medical errors. Introducing a system in the USA that allows for efficient access to such health data and ensures auditability of data facts, while avoiding data silos, will require fundamental changes in current practices. Here, we recommend the implementation of standardized data collection and transmission systems, universal identifiers for individual patients and end users, a reference standard infrastructure to support calibration and integration of laboratory results from equivalent tests, and modernized working practices. Requiring comprehensive and binding standards, rather than incentivizing voluntary and often piecemeal efforts for data exchange, will allow us to achieve the analytical information environment that patients need.
Keywords: Drug development; Public health.
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022.
Conflict of interest statement
Competing interestsThe authors declare no competing interests.
References
-
- WHO. Worldometer Coronavirus.https://www.worldometers.info/coronavirus/#countries (2022).
-
- NCB News. Government Watchdog Says Key Federal Health Agency is Failing on Crises.https://www.nbcnews.com/politics/politics-news/government-watchdog-says-... (2022).
-
- ISA. The Office of the National Coordinator for Health Information Technology. 2022 Interoperability Standards Advisory.https://www.healthit.gov/isa/sites/isa/files/inline-files/2022-ISA-Refer... (2022).
-
- U.S. FOOD & DRUG. COVID-19 Real World Data (RWD) Data Elements Harmonization Project.https://www.fda.gov/drugs/coronavirus-covid-19-drugs/covid-19-real-world... (2022).
Publication types
LinkOut - more resources
Full Text Sources